Yasutaka Maeda

Glucagon secretion and its association with glycaemic control and ketogenesis during sodium‐glucose cotransporter 2 inhibition by ipragliflozin in people with type 1 diabetes: Results from the multicentre, open‐label, prospective study

T. Kitamura, Y. Hirota, Tomoyasu Fukui, 2024, Diabetes, obesity & metabolism.